- Fee assured
- Verified this account
- Cardiac devices
- Coronary angiography
- Devices: cardiac resynchronisation therapy device (CRT)
- Devices: dual chamber pacemaker insertion
- Devices: implantable cardioverter defibrillator (ICD)
- Devices: single chamber pacemaker insertion
- Reporting of echocardiography
- Transthoracic echocardiography
Dr J Tomson qualified as a physician in 1999 and completed higher specialist training in Cardiology in the West Midlands (CCT) in 2015, and Cardiovascular research and epidemiology at Oxford (MD). He is a Consultant Cardiologist at the Royal Free London Hospitals and consults privately in London.
His specialist interests include cardiac rhythm management, cardiac device therapy (cardiac resynchronisation therapy, pacemakers, implantable cardioverter defibrillators), heart failure, cardiomyopathies, palpitations and syncope. He also has expertise in cardiovascular imaging, cardiovascular research including epidemiology and drug trials. He is a Member of the Royal College of Physicians (MRCP), and is a Certified Cardiac Device Specialist (CCDS) by the IBHRE. He conducts cardiovascular research and teaches medical students at the UCL, London.
Areas of interest
Cardiac Rhythm management; management of palpitations; loss of conciousness or syncope; Implant of Cardiac devices; heart failure; cardiac defibrillator; cardiac resynchronisation therapy; atrial fibrillation; breathlessness of cardiac cause; coronary disease; cardiovascular diseases; cardiac problems with chronic illnesses; cardiovascular research.
Current NHS consultant posts held
Consultant Cardiologist with interests in Cardiac Rhythm Management and Heart Failure.
Clinical Lead for Cardiology Outpatients
Royal Free Hospital,
London. NW3 2QG
Cardiovascular disease , Cardiac function, Arterial stiffness, Hypertension, Vitamin D and CVD, Epidemiology, and clinical evidence through Randomised controlled trials.Developing International research collaboration.
1. Tomson J, et al. Effects of vitamin D on blood pressure, arterial stiffness and cardiac function in older people after 1 year: BEST-D trial. J Am Heart Assoc. 2017 Oct 24;6(10)
2. HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017 Sep 28;377(13):1217-1227
3. Tomson J, Emberson J, Hill M, et al. Vitamin D and risk of death from vascular and nonvascular causes in the Whitehall study and meta-analyses of 12,000 deaths. European Heart journal. 2013 May;34(18):136574.
4. Tomson J, Bowman L, Armitage J. Concise guide to recommended lipid lowering drug treatment. Prescriber. 2011.
Courses offered to GPs
Managing atrial fibrillation in the community.
- MD University of Oxford 2016
- CCT Cardiology West Midlands Deanery 2015
- MRCP Royal College of Physicians 2004
- CCDS International Board of Heart Rhythm Examiners 2015
Reference number 5207347
Affiliations / memberships
- British Cardiovascular society (BCS)
- British society of heart failure (BSH)
- European society of cardiology (ESC)
- Royal college of Physicians, London (RCP)
- British Medical Association (BMA)
- Pond StreetLONDONNW3 2QG
- 09:00 - 11:00
- 020 7317 7751
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
firstname.lastname@example.org OR email@example.com
Call or leave a message on: 07854787111